
    
      This is a prospective multicenter phase IIIb randomized double-blind placebo-controlled
      study, to compare efficacy and tolerance of 3 groups of treatments for epicondylitis.

      All patients will be randomized in 3 following parallel treatment groups:

      Group A : botulinum toxin + corticoid

      Group C : placebo of toxin + corticoid

      Group T : botulinum toxin + placebo corticoid

      The study will be performed in 4 centers in France, targetting 150 patients. The follow-up of
      each patient will last 6 months after treatment.
    
  